Using the innovative DEPArray™ technology, scientists at Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company, were able to solve one of the biggest limitation in the ...
Genetic Profiles of Circulating Tumor Cells May Predict Drug Resistance and Clinical Outcomes BOLOGNA, Italy, and SAN DIEGO, Nov. 25, 2016 /PRNewswire/ --Menarini-Silicon Biosystems today announced ...
Using the innovative DEPArray technology, scientists at Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company, were able to solve one of the biggest limitation in the ...
Menarini Silicon Biosystems Spa, Castel Maggiore, Italy. An increasing body of evidence demonstrates that intra-tumor heterogeneity (ITH), resulting from subclonal branch alterations arising during ...
Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB's DEPArray technology* to successfully recover low numbers of ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--PGXL Technologies and Silicon Biosystems, Inc. announced a collaborative partnership to make the highly regarded Silicon Biosystems DEPArray technology available ...
Silicon Biosys¬tems Menarini and Macrogen, Inc has announced they will form a partnership to provide clinical assays and innovative procedures for precision medicine in cancer. The goal of the ...
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., June 18, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, will introduce its latest developments ...
In cancer research, studying individual cells can be life-saving. Cells that are dislodged from a tumour into the bloodstream indicate that the cancer is metastasizing and becoming more difficult to ...
Using the innovative DEPArray™ technology, scientists at Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company, were able to solve one of the biggest limitation in the ...
Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB's DEPArray technology* to successfully recover low numbers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results